Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of SARS-CoV-2 reinfection after natural infection
Rosemary J. Boyton, Daniel M. Altmann
The Lancet (2021) Vol. 397, Iss. 10280, pp. 1161-1163
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells
José Mateus, Jennifer M. Dan, Zeli Zhang, et al.
Science (2021) Vol. 374, Iss. 6566
Open Access | Times Cited: 290
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy
Laith J. Abu‐Raddad, Hiam Chemaitelly, Peter Coyle, et al.
EClinicalMedicine (2021) Vol. 35, pp. 100861-100861
Open Access | Times Cited: 173
COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection
Kevin Escandón-Vargas, Angela L. Rasmussen, Isaac I. Bogoch, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 165
Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: Results from the UK-REACH prospective nationwide cohort study
Katherine Woolf, I. C. McManus, Christopher Martin, et al.
The Lancet Regional Health - Europe (2021) Vol. 9, pp. 100180-100180
Open Access | Times Cited: 147
Recent developments in the immunopathology of COVID‐19
Huanping Zhang, Yuanli Sun, Yanfen Wang, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 369-388
Open Access | Times Cited: 67
COVID-19 vaccine strategies must focus on severe disease and global equity
Peter McIntyre, Rakesh Aggarwal, Ilesh Jani, et al.
The Lancet (2021) Vol. 399, Iss. 10322, pp. 406-410
Open Access | Times Cited: 78
Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients Undergoing Serial Laboratory Testing
Adnan I. Qureshi, William Baskett, Wei Huang, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 2, pp. 294-300
Open Access | Times Cited: 62
Risk of SARS-CoV-2 Reinfection 18 Months After Primary Infection: Population-Level Observational Study
Maria Elena Flacco, Graziella Soldato, Cecilia Acuti Martellucci, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 57
Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England
Anna Mensah, Helen Campbell, Julia Stowe, et al.
The Lancet Child & Adolescent Health (2022) Vol. 6, Iss. 6, pp. 384-392
Open Access | Times Cited: 47
Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants
Deepali Gupta, Priyanka Sharma, Mandeep Singh, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 24, pp. 7967-7989
Open Access | Times Cited: 51
Elucidating reasons of COVID-19 re-infection and its management strategies
Vijay Kumar Jain, Karthikeyan P. Iyengar, Rakesh Garg, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 3, pp. 1001-1006
Open Access | Times Cited: 48
SARS-CoV-2—The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6272-6272
Open Access | Times Cited: 33
Associations between psychiatric morbidity and COVID-19 vaccine hesitancy: An analysis of electronic health records and patient survey
Mara Eyllon, Alexander P. Dang, J Ben Barnes, et al.
Psychiatry Research (2021) Vol. 307, pp. 114329-114329
Open Access | Times Cited: 39
Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in a University Student Population
Lior Rennert, Christopher S. McMahan
Clinical Infectious Diseases (2021) Vol. 74, Iss. 4, pp. 719-722
Open Access | Times Cited: 37
Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients
Andrew D. Hoffmann, Sam Weinberg, Suchitra Swaminathan, et al.
Clinical Immunology (2023) Vol. 252, pp. 109634-109634
Open Access | Times Cited: 14
SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract
Frederick Hansen, Kimberly Meade‐White, Chad S. Clancy, et al.
Cell Reports (2022) Vol. 38, Iss. 11, pp. 110515-110515
Open Access | Times Cited: 20
A metaheuristic approach based on coronavirus herd immunity optimiser for breast cancer diagnosis
Ali Hosseinalipour, Reza Ghanbarzadeh, Bahman Arasteh, et al.
Cluster Computing (2024) Vol. 27, Iss. 7, pp. 9451-9475
Closed Access | Times Cited: 3
Low dose mRNA-1273 COVID-19 vaccine generates durable T cell memory and antibodies enhanced by pre-existing crossreactive T cell memory
José Mateus, Jennifer M. Dan, Zeli Zhang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 25
Optimal control and cost-effectiveness analysis for a COVID-19 model with individual protection awareness
Yiran Yuan, Ning Li
Physica A Statistical Mechanics and its Applications (2022) Vol. 603, pp. 127804-127804
Open Access | Times Cited: 18
Reinfection with SARS‐CoV‐2 in general population, South Korea; nationwide retrospective cohort study
Eun Jung Jang, Young June Choe, Go‐Woon Yun, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5589-5592
Open Access | Times Cited: 18
Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: Results from the UK-REACH prospective nationwide cohort study
Katherine Woolf, I. C. McManus, Christopher Martin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22
Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset
Jaclyn C. Law, Mélanie Girard, Gary Chao, et al.
The Journal of Immunology (2021) Vol. 208, Iss. 2, pp. 429-443
Open Access | Times Cited: 18
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria
Georgi K. Marinov, Младен Младенов, Antoni Rangachev, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0274509-e0274509
Open Access | Times Cited: 13
Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study
Clément Massonnaud, Jonathan Le Roux, Vittoria Colizza, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 479-479
Open Access | Times Cited: 12
Modeling SARS‐CoV‐2 True Infections in Catalonia through a Digital Twin
Pau Fonseca i Casas, Joan Garcia i Subirana, Víctor García i Carrasco
Advanced Theory and Simulations (2023) Vol. 6, Iss. 7
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top